ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Parexel International Corporation
88.08
0.0000
成交量：
- -
成交額：
- -
市值：
44.71億
市盈率：
37.64
高：
88.08
開：
88.08
低：
88.08
收：
88.08
52周最高：
88.10
52周最低：
51.16
股本：
5,076.20萬
流通股本：
4,990.34萬
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
2.34
淨資產收益率：
--
總資產收益率：
--
市淨率：
7.05
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Parexel International Corporation
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.parexel.com
郵編：
- -
電話：
- -
傳真：
- -
簡介：
Parexel International Corporation 是一家領先的生物製藥服務公司，致力於臨床研究、醫療通訊、諮詢、商業化和先進的技術產品，以及為全球製藥、生物技術以及醫療器械等行業服務方面有着專業技術。Parexel的主要目標是提供高質量的解決方案管理生物製藥產品生命周期以減少時間、風險，以及新療法的開發和商業化。Parexel於1983年註冊成立， Parexel在支持其公司戰略流程和技術方面有着卓越的專業技術。 PAREXEL的產品和所提供的服務包括：臨床試驗管理，觀察性研究和病人/疾病登記，數據管理，生物統計分析，流行病學，衛生經濟學/結果研究，藥物警戒，醫學交流，臨床藥理學，患者招募，上市后監測，監管產品開發和商業化的諮詢，衛生政策和報銷諮詢，業績改善，醫療成像服務， ClinPhone隨機化和試驗供應管理服務（ RTSM ） ，電子數據採集系統（ EDC ） ，臨床試驗管理系統（ CTMS ） ，基於Web的門戶網站，系統集成，患者日記應用程序和其他產品開發服務。 PAREXEL於1983年註冊成立為一家監管事務諮詢公司，是一家馬薩諸塞州公司。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PRXL/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"PRXL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRXL\",,,,,undefined,":{"symbol":"PRXL","market":"US","secType":"STK","nameCN":"Parexel International Corporation","latestPrice":88.08,"timestamp":1521662400000,"preClose":88.08,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":49903393,"shares":50762000,"eps":2.34,"marketStatus":"交易中","change":0,"latestTime":"03-10 13:30:28 EDT","open":88.08,"high":88.08,"low":88.08,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.34,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773172800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":816930000000,"exchange":"NASDAQ","adjPreClose":88.08,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRXL\",,,,,undefined,":{"symbol":"PRXL","floatShares":49903393,"roa":"--","roe":"--","lyrEps":0,"shares":50762000,"dividePrice":0,"high":88.08,"amplitude":0,"preClose":88.08,"low":88.08,"week52Low":51.16,"pbRate":"7.05","week52High":88.1,"institutionHeld":0.8988,"latestPrice":88.08,"eps":2.34,"divideRate":0,"volume":0,"delay":0,"ttmEps":2.34,"open":88.08,"prevYearClose":88.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRXL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-08-28","symbol":"PRXL","fiscalQuarterEnding":"2017/06","expectedEps":0.94,"name":null,"time":"盤後","type":"earning","dateTimestamp":1503892800000,"reportTimeType":"post","actualEps":1.02},{"market":"US","date":"2017-05-03","symbol":"PRXL","fiscalQuarterEnding":"2017/03","expectedEps":0.73,"name":null,"time":"盤後","type":"earning","dateTimestamp":1493784000000,"reportTimeType":"post","actualEps":0.74},{"market":"US","date":"2017-02-01","symbol":"PRXL","fiscalQuarterEnding":"2016/12","expectedEps":0.83,"name":null,"time":"盤後","type":"earning","dateTimestamp":1485925200000,"reportTimeType":"post","actualEps":0.85},{"market":"US","date":"2016-10-26","symbol":"PRXL","fiscalQuarterEnding":"2016/09","expectedEps":0.86,"name":null,"time":"盤後","type":"earning","dateTimestamp":1477454400000,"reportTimeType":"post","actualEps":0.76},{"market":"US","date":"2016-08-03","symbol":"PRXL","fiscalQuarterEnding":"2016/06","expectedEps":0.92,"name":null,"time":"盤後","type":"earning","dateTimestamp":1470196800000,"reportTimeType":"post","actualEps":0.94}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRXL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRXL\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.parexel.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Parexel International Corporation 是一家領先的生物製藥服務公司，致力於臨床研究、醫療通訊、諮詢、商業化和先進的技術產品，以及為全球製藥、生物技術以及醫療器械等行業服務方面有着專業技術。Parexel的主要目標是提供高質量的解決方案管理生物製藥產品生命周期以減少時間、風險，以及新療法的開發和商業化。Parexel於1983年註冊成立， Parexel在支持其公司戰略流程和技術方面有着卓越的專業技術。 PAREXEL的產品和所提供的服務包括：臨床試驗管理，觀察性研究和病人/疾病登記，數據管理，生物統計分析，流行病學，衛生經濟學/結果研究，藥物警戒，醫學交流，臨床藥理學，患者招募，上市后監測，監管產品開發和商業化的諮詢，衛生政策和報銷諮詢，業績改善，醫療成像服務， ClinPhone隨機化和試驗供應管理服務（ RTSM ） ，電子數據採集系統（ EDC ） ，臨床試驗管理系統（ CTMS ） ，基於Web的門戶網站，系統集成，患者日記應用程序和其他產品開發服務。 PAREXEL於1983年註冊成立為一家監管事務諮詢公司，是一家馬薩諸塞州公司。","exchange":"NASDAQ","name":"Parexel International Corporation","nameEN":"Parexel"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PRXL\",market:\"US\",,,undefined,":null}}